Eyal Breitbart

Eyal Breitbart began their work experience as the VP Research at VBL Therapeutics in January 2006. Eyal held this position until December 2013. In January 2014, Eyal moved up to become the VP Research & Operations at VBL Therapeutics. Eyal continued in this role until February 2022 when they were promoted to Senior Vice President Research & Operations. Eyal held this position until March 2023. Starting in March 2023, Eyal Breitbart became the Chief Production Officer at Orgenesis Inc. No end date for this role has been provided.

Eyal Breitbart holds a Doctor of Philosophy (Ph.D.) degree from Bar-Ilan University, which they obtained between the years 1995 and 1999. Eyal also completed a Post doc Fellowship at Tufts University School of Medicine, although the specific dates and field of study for this fellowship are not provided.